Antineoplastic tui tautaulaga-rhG-CSF

Faamatalaga oloa

Antineoplastic tautaulaga-rhG-CSF tui for the patients of non-myeloablative malignancy with the treatment of antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia. Antineoplastic tui tautaulaga-rhG-CSF e le o faaaogaina mo le tuufaatasiga o feaveai peripheral progenitor toto mo transplantation hematopoietic feaveai pogai.

Igoa o fualaau oona

Igoa lautele. Kolone PEGylated Recombinant Tagata Granulocyte faaosofia vala tui

Igilisi Igoa. Kolone PEGylated Recombinant Tagata Granulocyte faaosofia vala tui

Antineoplastic tui tautaulaga-rhG-CSF faʻamatalaga

suavai manino

Antineoplastic tui tautaulaga-rhG-CSFSa faailoa

1. E faaaoga mo le gasegase o malignancy lē myeloablative ma le togafitiga o antineoplastic, ina ua mafai ona i ai falemaʻi taua o febrile neutrophilic faaitiitia myelosuppression, e faaaoga ai lenei oloa e faaitiitia ai le incidence fua faatatau o siama e mafua mai i neutropenia febrile.

2. e le o faaaogaina lenei oloa mo le tuufaatasiga o feaveai progenitor peripheral toto mo transplantation hematopoietic feaveai pogai.

Antineoplastic tui tautaulaga-rhG-CSF Contraindication

E faasaina mo allergic e tautaulaga-rhG-CSF, rhG-CSF ma le faailoaga e.coli o isi gasegase preparations.The i ate serous, fatugao, loto, ua le atoatoa le malosi dysfunction māmā.

Antineoplastic tui tautaulaga-rhG-CSF Ata o Oloa

Antineoplastic tautaulaga-rhG-CSF Tuutuuga Femalagaaiga ma Tupe Totogi tui

Specification 3 mg/ml

afifiina 1 bottle/box

sauniuniga tui